Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease
- PMID: 19780902
- DOI: 10.1111/j.1471-4159.2009.06403.x
Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease
Abstract
Parkinson's disease (PD) is one of the most common movement disorders caused by the loss of dopaminergic neuronal cells. The molecular mechanisms underlying neuronal degeneration in PD remain unknown; however, it is now clear that genetic factors contribute to the pathogenesis of this disease. Approximately, 5% of patients with clinical features of PD have clear familial etiology, which show a classical recessive or dominant Mendelian mode of inheritance. Over the decade, more than 15 loci and 11 causative genes have been identified so far and many studies shed light on their implication in not only monogenic but also sporadic form of PD. Recent studies revealed that PD-associated genes play important roles in cellular functions, such as mitochondrial functions, ubiquitin-proteasomal system, autophagy-lysosomal pathway and membrane trafficking. Furthermore, the proteins encoded by PD-associated genes can interact with each other and such gene products may share a common pathway that leads to nigral degeneration. However, their precise roles in the disease and their normal functions remain poorly understood. In this study, we review recent progress in knowledge about the genes associated with familial PD.
Similar articles
-
Heredity in Parkinson's disease: new findings.Isr Med Assoc J. 2001 Jun;3(6):435-8. Isr Med Assoc J. 2001. PMID: 11433638 Review.
-
[The gene products for familial Parkinson's disease provide us hints to elucidate the mechanisms of nigral degeneration].Rinsho Shinkeigaku. 2004 Nov;44(11):821-3. Rinsho Shinkeigaku. 2004. PMID: 15651302 Review. Japanese.
-
Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.Pharmacol Ther. 2007 Jun;114(3):327-44. doi: 10.1016/j.pharmthera.2007.04.001. Epub 2007 Apr 19. Pharmacol Ther. 2007. PMID: 17521740 Review.
-
[The pathogenesis of Parkinson's disease: a hint from insights of familial Parkinson's disease].Rinsho Shinkeigaku. 2007 Nov;47(11):774-8. Rinsho Shinkeigaku. 2007. PMID: 18210796 Japanese.
-
Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?J Alzheimers Dis. 2010;19(1):1-9. doi: 10.3233/JAD-2010-1231. J Alzheimers Dis. 2010. PMID: 20061621 Review.
Cited by
-
Mitochondrial protein dysfunction in pathogenesis of neurological diseases.Front Mol Neurosci. 2022 Sep 7;15:974480. doi: 10.3389/fnmol.2022.974480. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36157077 Free PMC article. Review.
-
Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach.PLoS One. 2011 Feb 22;6(2):e16917. doi: 10.1371/journal.pone.0016917. PLoS One. 2011. PMID: 21364952 Free PMC article.
-
Serum metabolomics of slow vs. rapid motor progression Parkinson's disease: a pilot study.PLoS One. 2013 Oct 22;8(10):e77629. doi: 10.1371/journal.pone.0077629. eCollection 2013. PLoS One. 2013. PMID: 24167579 Free PMC article. Clinical Trial.
-
Selective susceptibility of human dopaminergic neural stem cells to dopamine-induced apoptosis.Exp Neurobiol. 2010 Dec;19(3):155-64. doi: 10.5607/en.2010.19.3.155. Epub 2010 Dec 31. Exp Neurobiol. 2010. PMID: 22110355 Free PMC article.
-
Genetic variants in diseases of the extrapyramidal system.Curr Genomics. 2014 Feb;15(1):18-27. doi: 10.2174/1389202914666131210213327. Curr Genomics. 2014. PMID: 24653660 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical